All Stories

  1. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis

    Article • Disease Markers, November 2019, Hindawi Publishing Corporation

    annalisa de silvestri, Dr Roberto Bergamaschi

  2. Interferon-beta injection site reactions in patients with multiple sclerosis

    Article • Journal of Dermatological Treatment, May 2018, Taylor & Francis

    Dr Roberto Bergamaschi

  3. Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI

    Article • Multiple Sclerosis Journal, August 2017, SAGE Publications

    Dr Roberto Bergamaschi

  4. Prognostic indicators in pediatric clinically isolated syndrome

    Article • Annals of Neurology, May 2017, Wiley

    Dr Tim Spelman, Dr Roberto Bergamaschi, Dr Emanuele D'amico

  5. Immunomodulatory therapies delay disease progression in multiple sclerosis

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr Roberto Bergamaschi

  6. Modeling the course and outcomes of MS is statistical twaddle—No

    Article • Multiple Sclerosis Journal, February 2016, SAGE Publications

    Dr Roberto Bergamaschi

  7. BREMSO: a simple score to predict early the natural course of multiple sclerosis

    Article • European Journal of Neurology, March 2015, Wiley

    Dr Roberto Bergamaschi